However, patients receiving CNIs appeared to have a higher risk of experiencing a transient increase in SCr (RR=0.42; 95% CI 0.14–1.21) and glucose disorder (RR=0.75; 95%CI 0.37–1.51) though this did not reach statistical significance.
← all excerpts
Calcineurin inhibitors may be a reasonable alternative to cyclophosphamide in the induction treatment of active lupus nephritis: A systematic review and meta-analysis.
1
—
—